The numbers are brutal and leave no room for spin. A study released on July 14, 2026, reveals that former NFL players are dying from amyotrophic lateral sclerosis (ALS) before age 50 at alarmingly high rates.
That is the finding. No context softens it. No caveat makes it acceptable.
The research examined mortality data among former players and discovered that the death rate from ALS in players under 50 far exceeds that of the general population. This study did not estimate or project; it recorded actual deaths, offering stark, undeniable data.
ALS, also known as Lou Gehrig's Disease, is a progressive neurodegenerative illness that attacks nerve cells in the brain and spinal cord. The average life expectancy after diagnosis is two to five years. Importantly, ALS carries a known association with head trauma and repetitive brain injury -- the very injuries inherent in professional football.
This is not a new concern. The NFL has faced scrutiny over its handling of brain health for years. The league settled a concussion lawsuit for nearly $1 billion in 2015. Researchers have linked chronic traumatic encephalopathy (CTE) to football at every level. Yet ALS has often remained in the background of public conversations -- a quieter, less common horror than CTE, but no less devastating to families.
What this study now does is quantify the scale of this horror for the first time in unequivocal terms.
The researchers describe the ALS rate among former NFL players under 50 as "alarmingly high." This clinical term signals numbers so stark that control groups and study groups are completely divergent. When scientists use words like "alarming," it means the data surged off the page.
Here is the sobering reality the league must confront: men who played in the NFL -- who dedicated their lives to becoming elite athletes, retired with pensions, and in many cases, enjoyed fame and fortune -- are dying of a fatal neurological disease before reaching 50. Not in their 70s or 60s, not even their 50s. Before 50.
This timeline robs a man of many fundamental life experiences: seeing his children graduate college, meeting his grandchildren, collecting Social Security benefits, or simply growing old.
The immediate question now is how the NFL will respond to this data. Historically, the league has reacted to health crises with rule changes and protocols introduced after the fact -- concussion protocols, kickoff rule changes, bans on helmet-to-helmet hits. Those are reactive, closing the barn door after the horse has bolted.
ALS, however, presents a different challenge. It is not caused by one traumatic impact but results from the cumulative effect of thousands of collisions over many years of play. You cannot simply change a single rule or ban a specific tackle and expect that ALS rates will significantly decline.
So what can be done?
The league can fund independent research dedicated to understanding the root causes and seeking treatments or preventive measures. It can provide resources for affected players and their families. It can maintain transparency with current players about the neurological risks they face.
Currently, the NFL and the NFL Players Association have a joint health and safety committee, a fund for retired players, and various medical research partnerships. However, the scale and severity of this study's findings demand that those efforts be accelerated, expanded, and prioritized above nearly all else.
Consider the timing. The league is preparing for the 2026 season. Training camps open in July. The regular season starts in September. Coaches are installing offensive and defensive schemes. General managers are finalizing rosters. Quarterbacks are building timing with receivers.
Meanwhile, somewhere, a former player who retired at 28 and appeared perfectly healthy might be receiving an ALS diagnosis that will end his life before he turns 45.
This is the painful reality behind the data -- and it is a story that no public relations effort can spin away.
The NFL has made progress. The game is safer now than it was 20 years ago, but safer is not safe enough. When men are dying from a preventable neurological disease at a rate researchers deem alarming, progress rings hollow.
The study does not name any players, and it does not need to. Every former player reading it knows the face that comes to mind. Every family who has lost a loved one to ALS understands the grim truth the study confirms.
The verdict is clear: the NFL must treat ALS as the existential crisis it is. That means funding truly independent, peer-reviewed research that publishes results without filters or PR influence. It means providing lifetime healthcare coverage for every player who has stepped onto an NFL field, not only those meeting current vesting criteria. It means openly and repeatedly communicating the risks to every player entering the league based on the best available data.
This study delivers a number. The men behind that number are real lives. The league owes them more than statements and committee meetings. It owes them decisive action.